Exploring the Complexity of Pan-Cancer: Gene Convergences and in silico Analyses

Leandro Teodoro1,2, Ana Claudia O Carreira1,3, Mari C Sogayar1,2

  • 1Cell and Molecular Therapy NUCEL Group, School of Medicine, University of São Paulo, São Paulo, São Paulo, 01246-903, Brazil.

PubMed

Insights

Pan-cancer studies reveal shared genetic patterns across tumor types, identifying common therapeutic targets for broader cancer treatment strategies. This research deepens understanding of tumorigenesis and tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer is a complex disease with intricate tumorigenesis and progression mechanisms, challenging diagnosis and treatment.
  • Targeted therapies offer personalized treatment but exploring genetic commonalities across cancers is crucial for broader strategies.

Purpose of the Study:

  • To provide a comprehensive overview of tumor biology, including tumorigenesis, the tumor microenvironment, and extracellular vesicles.
  • To explore molecular interactions driving tumor progression from a pan-cancer perspective.
  • To identify common and divergent genetic patterns across tumor types for potential therapeutic targets.

Main Methods:

  • In silico analysis of publicly available datasets.
  • Integration of concepts related to tumorigenesis, tumor microenvironment, and extracellular vesicles.
  • Comparative analysis of genetic and molecular patterns across diverse cancer types.

Main Results:

  • Identification of shared and distinct genetic and molecular patterns across different tumor types.
  • Insights into the complex interplay of factors influencing tumorigenesis and tumor progression.
  • Highlighting of potential common therapeutic targets applicable across multiple cancer types.

Conclusions:

  • Pan-cancer studies are vital for uncovering shared vulnerabilities and developing broadly applicable cancer therapies.
  • Understanding common genetic landscapes can lead to more effective and personalized treatment strategies.
  • This review consolidates knowledge on tumor biology and pan-cancer genetics, paving the way for future therapeutic development.